Abstract:Abstract Creation of new fluorophores is important for understanding the structure–property relationship, by which the required optical properties are likely to be attained. Herein, through theory calculation, it is found that furan‐modified thiadiazolo quinoxaline acting as an electron acceptor can endow donor–acceptor–donor (D–A–D) type second near‐infrared (NIR‐II) fluorophores with longer emission wavelength than the other thiadiazolo quinoxaline‐based acceptors containing pyridine, pyrrole, thiophene, and phenyl groups, respectively. On the basis of this theoretical prediction, a D–A–D type NIR‐II fluorophore with 6,7‐di(furan‐2‐yl)‐[1,2,5]thiadiazolo[3,4‐g] quinoxaline (DFTQ) as the acceptor and dithieno[3,2‐b:2′,3′‐d]pyrrole (DTP) as the donor is designed and synthesized, and the aggregation‐induced emission (AIE) function is further achieved by introducing the AIE units of tetraphenylethylene (TPE) and triphenylamine (TPA), respectively, totally forming three NIR‐II fluorophores DFTQ–DTP, DFTQ–DTPE, and DFTQ–DTPA. For biological applications, the fluorophores are encapsulated by amphiphilic DSPE–PEG2000 to generate water‐dispersible nanoparticles (NPs). Almost the whole emission of each of the NPs falls into the NIR‐II spectral range, with part emission beyond 1300 nm. By using DFTQ–DTPA NPs as the contrast and photothermal therapy (PTT) agent, high‐resolution in vivo fluorescence imaging is achieved in the greater than 1300 nm window, and their good performance in photoacoustic imaging and high tumor PTT efficacy in tumor‐bearing mice are also demonstrated. Taken together, this work mainly provides a strong electron acceptor for constructing long‐emitting fluorophores, and by using the electron acceptor, a AIE fluorophore with desirable quantum yield (QY) and photothermal conversion efficienciy (PCE) is synthesized and demonstrated to be promising in fluorescence/photoacoustic imaging and PTT.

Reengineering of Donor-Acceptor-Donor Structured Near-Infrared II Aggregation-Induced Emission Luminogens for Starving-Photothermal Antitumor and Inhibition of Lung Metastasis

Synchronously Manipulating Absorption and Nonradiative Transition of Croconaine Via Donor Engineering for Efficient NIR-II Photothermal Theranostics

Donor-Acceptor Modulating of Ionic AIE Photosensitizers for Enhanced ROS Generation and NIR-II Emission

Unusual Electron Donor-Acceptor Sequenced NIR AIEgen for Highly Efficient Mitochondria-Targeted Cancer Cell Photodynamic Therapy.

Bright “D-A-D” Semiconducting Small Molecule Aggregates for NIR-II Fluorescence Bioimaging Guiding Photothermal Therapy

Donor–Acceptor–Donor Near-Infrared-II Aggregation-Induced Emission Luminogens (AIEgens) Encapsulated within Nanometer-Sized Exosomes for Tumor Imaging

Furan‐modified Thiadiazolo Quinoxaline As an Electron Acceptor for Constructing Second Near‐infrared Aggregation‐induced Emission Fluorophores for Beyond 1300 Nm Fluorescence/photoacoustic Imaging and Photothermal Therapy

Facilely Achieving Near-Infrared-II J-Aggregates through Molecular Bending on a Donor-Acceptor Fluorophore for High-Performance Tumor Phototheranostics

Molecular Engineering Design of Enhanced Donor-Acceptor Therapeutic Reagent for Efficient Image-Guided Photodynamic Therapy

Second Near-Infrared Aggregation-Induced Emission Fluorophores with Phenothiazine Derivatives As the Donor and 6,7-Diphenyl-[1,2,5]thiadiazolo[3,4-g]quinoxaline As the Acceptor for in Vivo Imaging

Acceptor engineering of semiconducting oligomers for improved NIR-II fluorescence imaging and therapy

Acceptor engineering for NIR-II dyes with high photochemical and biomedical performance

Add the Finishing Touch: Molecular Engineering of Conjugated Small Molecule for High‐Performance AIE Luminogen in Multimodal Phototheranostics

Zwitterionic AIEgens: Rational Molecular Design for NIR‐II Fluorescence Imaging‐Guided Synergistic Phototherapy

NIR-II Fluorophore with Dithienylethene as an Electron Donor for Fluorescence/Photoacoustic Dual-Model Imaging and Photothermal Therapy

NIR-II Emissive Donor-Acceptor-Donor Fluorophores for Dual Fluorescence Bioimaging and Photothermal Therapy Applications

Dual-modal Imaging-Guided Agent Based on NIR-II Aggregation-Induced Emission Luminogens with Balanced Phototheranostic Performance

De Novo Design of Reversibly pH-Switchable NIR-II Aggregation-Induced Emission Luminogens for Efficient Phototheranostics of Patient-Derived Tumor Xenografts

Theoretical Insights into Rational Design of Small Organic Phototheranostic Agents for Promoting Image-Guided Cancer Surgery

Donor-Acceptor Typed AIE Luminogens with Near-infrared Emission for Super-resolution Imaging

D-A-D organic small molecules with AIE effect for fluorescence imaging guided photothermal therapy.